STXS Stereotaxis Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: STXS

Price (delayed)

$1.87

Market cap

$182.77M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.24

Enterprise value

$173.43M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 20

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic ...

Highlights
STXS's quick ratio has soared by 69% YoY
The EPS has grown by 23% YoY and by 4% from the previous quarter
STXS's revenue is up by 13% YoY but it is down by 3.7% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.stereotaxis.com
Peers: BSX EW ATRC JNJ

Key stats

What are the main financial stats of STXS

STXS stock price

How has the Stereotaxis stock price performed over time
Intraday
1.63%
1 week
-10.1%
1 month
-1.58%
1 year
-18.34%
YTD
-18.7%
QTD
1.63%

Financial performance

How have Stereotaxis's revenue and profit performed over time
Revenue
$31.2M
Gross profit
$16.8M
Operating income
-$22.16M
Net income
-$21.68M
Gross margin
53.9%
Net margin
-69.5%
Stereotaxis's net margin has increased by 25% YoY but it has decreased by 4% from the previous quarter
STXS's operating margin is up by 25% YoY but it is down by 4% from the previous quarter
The net income has grown by 15% YoY
STXS's operating income is up by 14% year-on-year

Price vs fundamentals

How does STXS's price correlate with its fundamentals

Growth

What is Stereotaxis's growth rate over time

Valuation

What is Stereotaxis stock price valuation
P/E
N/A
P/B
12.67
P/S
5.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.56
The EPS has grown by 23% YoY and by 4% from the previous quarter
STXS's P/B is 75% below its last 4 quarters average of 49.6 and 41% below its 5-year quarterly average of 21.2
STXS's equity is up by 7% since the previous quarter
The stock's price to sales (P/S) is 23% less than its 5-year quarterly average of 7.6 and 16% less than its last 4 quarters average of 6.9
STXS's revenue is up by 13% YoY but it is down by 3.7% from the previous quarter

Efficiency

How efficient is Stereotaxis business performance
Stereotaxis's return on equity has increased by 32% QoQ and by 25% YoY
The ROS has grown by 25% YoY but it has contracted by 4% from the previous quarter
Stereotaxis's ROA has increased by 20% YoY and by 4% from the previous quarter
STXS's return on invested capital is up by 18% year-on-year and by 14% since the previous quarter

Dividends

What is STXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STXS.

Financial health

How did Stereotaxis financials performed over time
The company's total assets is 57% higher than its total liabilities
STXS's quick ratio has soared by 69% YoY
The current ratio has grown by 46% YoY and by 3.3% from the previous quarter
Stereotaxis's debt is 63% less than its equity
STXS's debt to equity has dropped by 82% year-on-year and by 8% since the previous quarter
Stereotaxis's debt has decreased by 10% YoY and by 2.9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.